Liposomes, micelles and microemulsions as new delivery systems for cytotoxic alkaloids

Pharmaceutical Science and Technology Today

Volumn 2, Issue 7, 1999, Pages 288-298

  Cortesi, Rita ^b   Nastruzzi, Claudio ^a  

^a Ist di Chim e Tecn del Farmaco   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; MICELLE; NONHUMAN; REVIEW; TUMOR;

EID: 0033166573     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00171-6     Document Type: Review

References (77)

1. Waterman P.G. Cordell G.A. The Alkaloids. Chemistry and Biology. 1998;537-566 Academic Press, San Diego, CA, USA.
2. Remington's Pharmaceutical Sciences (18th Edn) (Gennaro, A.R., ed.), Mack Publishing Company, Easton, PA, USA.
3. Campbell W.E.et al. Planta Med. 64:1998;91-93.
4. Keawpradub N.et al. Planta Med. 63:1997;97-101.
5. Chen I.S.et al. Planta Med. 63:1997;154-157.
6. Long B.H.et al. Cancer Res. 58:1998;1111-1115.
7. Fiserová A.et al. Physiol. Res. 46:1997;119-125.
8. Ozeki A.et al. J. Nat. Prod. 61:1998;776-780.
9. Dong Y., Yang M.M., Kwan C.Y. Life Sci. 60:1997;135-140.
10. Pang L., Hoult J.R. Biochem. Pharmacol. 53:1997;773-782.
11. Rahman A., Choudhari M.I. Cordell G.A. The Alkaloids. Chemistry and Biology. 1998;61-108 Academic Press.
12. Száni C. Cordell G.A. The Alkaloids. Chemistry and Biology. 1998;509-563 Academic Press.
13. Rowinsky E.K. Annu. Rev. Med. 48:1997;353-374.
14. Wall M.E. Med. Res. Rev. 5:1998;299-314.
15. Wall M.E., Wani M.C. Cordell G.A. The Alkaloids. Chemistry and Biology. 1998;509-563 Academic Press.
16. Sharma A.et al. Int. J. Cancer. 71:1997;103-107.
17. Scialli A.R.et al. Pharmacology. 51:1995;145-151.
18. Terwogt J.M.et al. Cancer Treat. Rev. 23:1997;87-95.
19. Sharma D.et al. Melanoma Res. 8:1998;240-244.
20. Dancey J., Eisenhauer E.A. Br. J. Cancer. 74:1996;327-338.
21. Bodley A.L.et al. Biochem. Pharmacol. 50:1995;937-942.
22. Slichenmyer W.J.et al. J. Natl. Cancer Inst. 85:1993;271-291.
23. Muggia F.M.et al. Cancer Chemother. Res. 56:1972;515-521.
24. Sharma A., Sharma U.S. Int. J. Pharm. 154:1997;123-140.
25. Cortesi R.et al. Int. J. Pharm. 159:1997;95-103.
26. Gabizon A. Roerdink F.H.D., Kroo A.M. Drug Carrier System. 1989;185-211 John Wiley & Sons Ltd, Chichester, UK.
27. Chonn A., Cullis P.R. Curr. Opin. Biotechnol. 6:1995;698-708.
28. Pavliv L., Tyle P., Johnston A. PDA J. Pharm. Sci. Technol. 49:1995;9-12.
29. Mori A., Kennel S.J., Huang L. Pharm. Res. 10:1993;507-514.
30. Griffin T.et al. J. Natl. Cancer Inst. 85:1993;292-298.
31. Sugarman S.M., Perez-Soler R. Crit. Rev. Oncol. Hematol. 12:1992;231-242.
32. De Oliveira A.G., Chaimovich H. J. Pharm. Pharmacol. 45:1993;850-861.
33. Attwood D. Kreuter J. Colloidal Drug Delivery Systems. 1994;31-71 Marcel Dekker Inc, New York, NY, USA.
34. Kakemi K.et al. Chem. Pharm. Bull. 18:1993;275-280.
35. Kanter P.M.et al. Anti-Cancer Drugs. 5:1994;579-590.
36. Warren L.et al. Cancer Res. 52:1992;3241-3245.
37. Embree L.et al. Cancer Chemother. Pharmacol. 41:1998;347-352.
38. Boman N.L.et al. Cancer Chemother. Pharmacol. 37:1996;351-355.
39. Mayer L.D.et al. Cancer Res. 50:1990;575-579.
40. Mayer L.D.et al. Biochim. Biophys. Acta. 816:1985;294-302.
41. Berleur F.et al. Biochem. Pharmacol. 34:1985;3081-3086.
42. Sharma A.et al. J. Pharm. Sci. 84:1995;1400-1404.
43. Sharma A., Straubinger R.M. Pharm. Res. 11:1994;889-896.
44. Rafaeloff R., Husain S.R., Rahman A. Proc. Am. Assoc. Cancer Res. 33:1992;482-487.
45. Straubinger R.M.et al. J. Natl. Cancer Inst. Monogr. 15:1993;69-78.
46. Scialli A.R.et al. Teratology. 56:1997;305-310.
47. Sharma A., Mayhew E., Straubinger R.M. Cancer Res. 53:1993;5877-5881.
48. Cabanes A.et al. Int. J. Oncol. 15:1998;1035-1040.
49. Sharma A., Sharma U.S., Straubinger R.M. Cancer Lett. 107:1996;265-272.
50. Riondel J.et al. In Vivo. 6:1992;23-27.
51. Lundberg B.B. Anticancer Drug Des. 12:1997;503-513.
52. Burke T.G., Gao X. J. Pharm. Sci. 83:1994;967-969.
53. Clements M.K., Wasi S., Daoud S.S. Anti-Cancer Drugs. 7:1996;851-857.
54. Daoud S.S., Fetouh M.I., Giovanella B.C. Anti-Cancer Drugs. 6:1995;83-93.
55. Sadzuka Y., Hirotsu S., Hirota S. Cancer Lett. 127:1998;99-106.
56. Lundberg B.B. Anticancer Drug Des. 13:1998;453-461.
57. Alkan Onyksel H.et al. Pharm. Res. 11:1994;206-212.
58. Nastruzzi C., Gambari R. J. Control. Release. 29:1994;53-62.
59. Hui K.M.et al. Gene Ther. 4:1997;783-790.
60. Vail D.M.et al. Clin. Cancer. Res. 4:1998;1567-1571.
61. Yerushalmi N., Margalit R. Biochim. Biohys. Acta. 1189:1994;13-20.
62. Foldvari M., Gesztes A., Mezei M. J. Microencapsulation. 4:1990;479-483.
63. Rougier A.et al. J. Invest. Dermatol. 84:1985;66-68.
64. Du Plessis J., Egbaria K., Weiner N. J. Soc. Cosmet. Chem. 43:1992;93-9999.
65. Du Plessis J., Weiner N., Muller D. Int. J. Pharm. 103:1994;R1-R5.
66. Gabrijelcic V., Sentjurc M., Schara M. Int. J. Pharm. 102:1994;151-158.
67. Elias P.M. J. Control. Release. 15:1991;199-205.
68. Abraham W., Downing D.T. J. Invest. Dermatol. 93:1989;809-813.
69. Brandau, R. and Lippold, B.H. (1982) Dermal and Transdermal Absorption, Wissenschaftliche Verlagsgesellschaft GMbH, Stuttgart, Germany
70. Rolland A.et al. Int. J. Pharm. 76:1991;217.
71. Mahjour M.et al. J. Control. Release. 14:1990;243-252.
72. Scartazzini R., Luisi P.L. J. Phys.Chem. 92:1988;829-833.
73. Walde P.et al. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 17:1990;421-422.
74. Esposito E.et al. Gambari R., Nastruzzi C. Tissue Cultures in Cosmetic Biotechnology. 1992;107-112.
75. Bartolazzi A.et al. In Vivo. 3:1989;383-388.
76. Nastruzzi C., Gambari R. J. Control. Release. 29:1994;53-62.
77. Williman H.et al. J. Pharm. Sci. 81:1992;871-874.